Development of a membrane-controlled transdermal therapeutic system containing isosorbide dinitrate

International Journal of Pharmaceutics

Volumn 180, Issue 2, 1999, Pages 177-183

  Ocak, Fígen ^a   Agabeyoglu, Ílbeyí ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Diffusion coefficient; Ethylene vinyl acetate; Isosorbide dinitrate; Polyethylene membrane; Release kinetics; Transdermal therapeutic systems

Indexed keywords

CARBOMER; CARBOPOL 934; ETHYLENE VINYL ACETATE COPOLYMER; ISOSORBIDE DINITRATE; POLYETHYLENE;

ARTICLE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; MATHEMATICAL MODEL; PHARMACOKINETICS; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; TRANSDERMAL DRUG ADMINISTRATION; ULTRAVIOLET SPECTROPHOTOMETRY;

ADHESIVENESS; ADMINISTRATION, CUTANEOUS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ISOSORBIDE DINITRATE; KINETICS; MEMBRANES, ARTIFICIAL; PERMEABILITY; POLYETHYLENES; POLYVINYLS; VASODILATOR AGENTS;

EID: 0032915258     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00005-8     Document Type: Article

References (18)

1. Agabeyoglu Í. Un programme dans la langue BASIC de microcomputer pour la determination des donnees de dissolution. 1984;XVIIIeme Semaine Medicale Balkanique, Istanbul.
2. Anon Transdermal delivery systems - general drug release standards. Pharmacopeial Forum. 14:1980;3860-3865.
3. Anon Technical Data Sheet 3M Laboratories (Europe). 1988.
4. Chasseaud L.F., Down W.H., Grundy R.K. Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects. Eur. J. Clin. Pharmacol. 8:1975;157-160.
5. Chien Y.W. Transdermal systemic drug delivery recent development and future prospects. S.T.P. Pharma. Sci. 1:1990;15-23.
6. Dittgen M., Bombor R. Transdermal controlled release pharmaceutical films containing solvent. Ger. (East) DD, 217 989 A. 1989;1.
7. Down W.H., Chasseaud L.F., Grundy R.K. Biotransformation of isosorbide dinitrate in humans. J. Pharm. Sci. 63:1974;1147-1149.
8. Fung H.L. Nitrate formulations and drug delivery systems - an overview. Z. Kardiol. 74(Suppl. 4):1985;4-9.
9. Johnson K.I., Gladigau V., Schnelle K. Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained release formulations of isosorbide dinitrate in normal man. Arzneim.-Forsch. Drug Res. 31:1981;1026-1029.
10. Kagayama A., Mustafa R., Akoho E., Khawam N., Truelove J., Hussain A. Mechanism of diffusion of compounds through ethylene vinyl acetate copolymers I. Kinetics of diffusion of 1-chloro-4-nitrobenzene, 3-4-dimethylphenol and 4-hexylresorcinol. Int. J. Pharm. 18:1984;247-258.
11. Morimoto Y., Seki T., Sugibayashi K., Juni K., Miyazaki S. Basic studies on controlled transdermal delivery of nicardipine hydrochloride using ethylene-vinyl acetate and ethylene-vinyl alcohol copolymer membranes. Chem. Pharm. Bull. 36:1988;2633-2641.
12. Peterson T., Burton S., Englund B., Grosh S. In vitro permeability of poly(ethylene-vinyl acetate) and microporous polyethylene membranes. Proc. Int. Symp. Control. Release Bioactiv. Mater. 17:1990;411-412.
13. Robinson J.R., Eriksen S.P. Theoretical formulation of sustained release dosage forms. J. Pharm. Sci. 55:1966;1254-1263.
14. Straehl P., Galeazzi R.L. Isosorbide dinitrate bioavailability, kinetics and metabolism. Clin. Pharmacol. Ther. 38:1985;140-149.
15. Takada K., Yoshikawa H., Muranishi S. Pharmacokinetic analysis of plasma drug level data obtained from a transdermal therapeutic system with complex absorption model. Int. J. Pharm. 65:1990;159-167.
16. Taylor T., Chasseaud L.F., Doyle E., Bonn R., Darragh A., Lampe R.F. Isosorbide dinitrate pharmacocinetics. Arzneim.-Forsch. Drug Res. 32:1982;1329-1333.
17. Taylor T., Chasseaud L.F., Major R.M., Leaf F.C., Bonn R., Darragh A., Lampe R.F. Bioequivalence of a sustained release isosorbide dinitrate formulation at steady-state. Biopharm. Drug Dispos. 6:1985;119-129.
18. Wildfeuer V.A., Laufen H., Leitold M. Pharmacologie von Isosorbiddinitrat nach transdermaler Applikation. Arzneim.-Forsch. Drug Res. 35:1985;1289-1291.